REG - Futura Medical PLC - Grant of Options <Origin Href="QuoteRef">FUM.L</Origin>

Futura MedicalAnnouncement

10/09/2015 07:01

RNS Number : 6071Y
Futura Medical PLC
10 September 2015
For immediate release
10 September 2015
Futura Medical plc
("Futura" or the "Company")
Grant of Options
Futura Medical plc (AIM: FUM), the innovative healthcare company focused on advanced transdermal technology, announces that on 9 September 2015 it granted options over a total of 400,000 ordinary shares of 0.2p each in the Company to Directors as detailed below.
Director
Number
of options
granted
Exercise
price
Exercise
period
Total number
of options
held following
notification
Total number
of ordinary
shares held
J H Barder
250,000
30.0p
1 Oct 2017 - 30 Sep 2022
1,500,000
1,008,830
D A Martin
150,000
30.0p
1 Oct 2017 - 30 Sep 2022
869,279
280,000
The new options were granted under the Futura Medical plc Unapproved Share Option Scheme.
The main vesting condition of the options is that the Directors remain employed with the Company as at the date of exercise.
For further information please contact:
Futura Medical plc

James Barder, Chief Executive
Tel: +44 (0) 1483 685 670
Email to: james.barder@futuramedical.com
www.futuramedical.com
N+1 Singer (Nominated Adviser and Broker)

Aubrey Powell / Liz Yong / Tom Smale - Corporate Finance 
Tel:+44 (0) 20 7496 3000
For media enquiries please contact: 

Buchanan 

Mark Court / Sophie Cowles / Stephanie Watson
Tel: +44 (0) 20 7466 5000


Notes to Editors
Futura Medical plc
Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.
Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.
www.futuramedical.com

This information is provided by RNS
The company news service from the London Stock Exchange
  END
RDSLLFIDAEIAIIE